Abstract. Lipomas are common benign soft tissue tumors whose genetic and cytogenetic features are well characterized. The karyotype is usually near-or pseudodiploid with characteristic structural chromosomal aberrations. The most common rearrangements target the high mobility group AT-hook 2 (HMGA2) gene in 12q14.3, with breakpoints occurring within or outside of the gene locus leading to deregulation of HMGA2. The most common fusion partner for HMGA2 in lipoma is lipoma-preferred partner (3q27), but also other genes frequently recombine with HMGA2. Furthermore, truncated HMGA2 transcripts are recurrently observed in lipomas. The present study describes 5 lipomas carrying the translocation t(4;12)(q27~28;q14~15) as the sole chromosomal anomaly, as well as 1 lipoma in which the three-way translocation t(1;4;12)(q21;q27~28;q14~15) was identified. Molecular analyses performed on 4 of these cases detected 4 truncated forms of HMGA2. In 3 tumors, the HMGA2 truncated transcripts included sequences originating from the chromosomal sub-band 4q28.1. Notably, in 2 of these cases, the fourth exon of HMGA2 was fused to transposable elements located in 4q28.1.
Introduction
Lipomas are common fat cell tumors that most often occur in middle-aged or elderly patients. Lipomas may arise subcutaneously (superficial lipomas) or in deep soft tissues (deep-seated intra-or intermuscular lipomas). Superficial lipomas are usually smaller (<5 cm) than their deep-seated counterparts (>5 cm) (1) . The genetic features of lipomas have been characterized in considerable detail. The karyotype of lipomas (2-4) is usually near-or pseudodiploid with structural chromosomal rearrangements, the most common of which involve the chromosomal segment 12q13~15 (5) . According to the Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (http://cgap.nci.nih.gov/Chromosomes/Mitelman; database updated on May 7, 2015) , 476 lipomas have been reported with chromosomes aberrations, with 12q13~15 being targeted in >300 of them. The recombination with 12q13~15 occurs with multiple other chromosome bands, the most common of which is 3q27~28, corresponding to the translocation t(3;12)(q27~28;q14~15). Other chromosome segments that are frequently recombined with 12q13~15 are 1p36, 1p32~34, 2p22~24, 2q35~37, 5q33, 9p21~22, 12p11~13 and 13q12~14. The rearrangements often target the high mobility group AT-hook 2 (HMGA2) gene in 12q14.3, regardless of whether the breakpoints occur within or outside the gene locus; the essential outcome is the deregulation of HMGA2. The most common gene fusing with HMGA2 in lipoma is lipoma-preferred partner (LPP) (3q27) (6) , but also other genes located in the common breakpoint regions are known to recombine with HMGA2 recurrently. In addition, the chromosomal rearrangements may occasionally lead to truncated HMGA2 transcripts (7) .
According to the Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, the translocation t(4;12)(q27;q15) and variants thereof have been reported in 6 lipomas: In 2 of them, as the sole chromosomal aberration; in other 2, as a three-way translocation; and in the last 2, as part of more complex karyotypes (http://cgap.nci.nih.gov/Chromosomes/Mitelman; database updated on May 7, 2015) . The present study describes another 5 cases of lipoma carrying the t(4;12)(q27~28;q14~15) as a sole anomaly and 1 case with a three-way translocation. Molecular analyses were performed on 4 of the tumors in order to discover the putative gene partner from 4q27~28 recombining with HMGA2, but none was identified. Instead, the analysis revealed 4 truncated forms of HMGA2 in the examined samples. The HMGA2 truncated transcripts included sequences located in the chromosomal sub-band 4q28.1 in 3 of these cases. Chromosome banding analysis. Samples from the operation specimens were mechanically and enzymatically disaggregated and short-term cultured as described by Mandahl (8) . The cultures were harvested, and the chromosomes were G-banded using Wright's stain (Sigma-Aldrich, St. Louis, MO, USA). The subsequent cytogenetic analysis and karyotype description followed the recommendations of the International System for Human Cytogenetic Nomenclature (9).
Materials and methods

Ethics
RNA extraction. Tumor tissue adjacent to that used for cytogenetic analysis and histologic examination had been frozen and stored at -80˚C from 4 tumors (cases 1-4). Total RNA was extracted using miRNeasy kit, TissueLyser II and QIAcube according to the manufacturer's protocol (Qiagen GmbH, Hilden, Germany). The concentration and purity of the RNA was measured with the NanoVue Spectrophotometer (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA).
3'-Rapid amplification of complementary DNA (cDNA) ends (3'-RACE).
3'-RACE was performed using a protocol described previously (10) . Total RNA (100 ng) was reverse-transcribed in a 20-µl reaction volume using A3RNV-RACE (5'-ATC GTT GAG ACT CGT ACC AGC AGA GTC ACG AGA GAG ACT ACA CGG TAC TGG TTT TTT TTT TTT TT-3') as a primer and iScript Select cDNA Synthesis kit (Bio-Rad Laboratories AB, Oslo, Norway) according to the manufacturer's protocol. cDNA (1 µl) was used as template and amplified in a polymerase chain reaction (PCR) using the outer primer combination HMGA2-846F1 (5'-CCA CTT CAG CCC AGG GAC AAC CT-3') and A3R-1New (5'-TCG TTG AGA CTC GTA CCA GCA GAG TCAC-3'). PCR cycling conditions consisted of an initial step of denaturation at 94˚C for 30 sec, followed by 35 cycles of 7 sec at 98˚C, 2 min at 68˚C and a final extension for 5 min at 72˚C. In total, 1 µl of the amplified products was used as template in nested PCR with the primers HMGA2-982F1 (5'-CAA GAG TCC CTC TAA AGC AGC TCA-3') and A3R3 (5'-CGA GAG AGA CTA CAC GGT ACT GGT-3'). The nested PCR was performed using the Touchdown-PCR conditions described by Korbie and Mattick (11) in order to increase the specificity of the PCR and improve the quality of the products. For both PCRs, the 25-µl reaction volume contained 12.5 µl Premix Ex Taq (Takara Bio Europe SAS, Saint-Germain-en-Laye, France), template, and 0.4 µM of each of the forward and reverse primers. PCR products (3 µl) were stained with GelRed™ (Biotium, Inc., Hayward, CA, USA) and analyzed by electrophoresis using 1.0% agarose gels. The gel was scanned with G:BOX (Syngene, Frederick, MD, USA), and the images were acquired using GeneSnap (Syngene). The remaining 22 µl of the amplified fragments were purified using the QIAquick PCR purification kit (Qiagen AB). Direct sequencing was performed using the LIGHTRUN™ Sequencing Service of GATC Biotech (Konstanz, Germany; www.gatc-biotech. com/en/products/sanger-services/lightrun-sequencing.html). The Basic Local Alignment Search Tool (BLAST; http://blast.ncbi.nlm.nih.gov/Blast.cgi) and BLAST-like alignment tool (http://genome.ucsc.edu/cgi-bin/hgBlat) programs were used for computer analysis of the sequencing data. Table I contains the patients' gender, age and diagnosis, and the location, karyotype, HMGA2 expression and HMGA2 fusions of the examined lipomatous tumors. In all 6 cases (3 males and 3 females), there was recombination between the chromosome bands 12q14~15 and 4q27~28. In total, 5 cases carried t(4;12)(q14~15;q27~28) as the sole karyotypic aberration, whereas 1 lipoma (case 2) had a three-way translocation t(1;4;12)(q21;q27~28;q14~15) (Fig. 1) . Table I ) amplified fragments which were revealed to be chimeric HMGA2-cDNA fragments by Sanger sequencing analysis (Fig. 2) . In lipomas 1, 2 and 4, HMGA2 was fused with sequences from intergenic regions of 4q28.1. In lipoma 1, the exon 4 of HMGA2 was fused with the transposable elements long interspersed element L2a and mammalian interspersed repetitive located in 4q28.1 (Fig. 3) , whereas lipoma 2 exhibited HMGA2 exon 3 fused with a circa 750-bp fragment from band 4q28.1. In lipoma 4, HMGA2 exon 4 was fused with two Alu sequences from chromosome band 4q28.1 B A (Fig. 3) . In lipoma 3, the third exon of HMGA2 was fused with two HMGA2 intron 3 sequences of 469 and 305 bp, respectively, with a distance between them of ~75 kbp.
Results
Pathology and cytogenetics.
Molecular genetics. 3'-RACE on the lipomas of cases 1-4 (
Discussion
HMGA1 and HMGA2 are non-histone proteins involved in a wide variety of nuclear processes, from chromatin dynamics to gene regulation (12) . HMGA family genes are expressed during embryonic development (13) , but are largely unexpressed in adult normal tissues (14) . High expression levels of HMGA2 in tissues are usually associated with neoplastic transformation (15) . Indeed, recent studies highlight a pivotal role of HMGA2 in cancer pathogenesis and progression (16) . The HMGA2 gene has been previously observed to be disrupted, due to rearrangement of chromosomal bands 12q13~15, in different connective tissue tumors, including lipomas (7), pleiomorphic adenomas of the salivary gland (17), uterine leiomyomas (18) and lung hamartomas (19) . These alterations usually involve exon 3 and cause deletion of downstream regions, leading to a truncated transcript that can evade microRNA-dependent gene silencing (20) . Alternatively, chromosomal rearrangements of 12q13~15 may lead to the formation of a fusion gene (15) . In lipoma tumorigenesis, the most common fusion partner for HMGA2 is LPP (3q27). Other frequent fusion partners of HMGA2 are C-X-C chemokine receptor type 7 (2q37), early B-cell factor 1 (5q33) and neurofibromin 1B (9p23) (5) . The present analyses revealed that the translocation t(4;12)(q27~28;q14~15) is recurrent in lipomas and leads to the truncation of HMGA2. Notably, 4 of the 6 lipomas analyzed were intramuscular and large; whether this represents a general feature of t(4;12)-positive tumors remains to be investigated. In 3 lipomas (cases 1, 2 and 4), sequences located in 4q28.1 were fused with HMGA2. The ensuing HMGA2-fusion transcripts coded for putative proteins which contain amino acid residues 1-83 of HMGA2 protein (accession number NP_003474.1), corresponding to exons 1-3 of the HMGA2 gene, and amino acid residues from the fused sequences. This pattern is similar to that observed as a result of other rearrangements of HMGA2 in lipomas, where disruption of the HMGA2 locus leaves intact exons 1-3 of the gene (which encode the AT-hooks domains) and separates them from the 3'-terminal part of the gene (12) . Notably, in cases 1 and 4, the HMGA2 exon 4 was fused with transposable elements. The Human Genome Project findings predicted that approximately half of the genome consists of such elements, which are capable of integrating at new genomic sites within the cell of origin (21) , thus leading to transposable element-driven transcript diversification mediated by alternative splicing (22) .
In conclusion, the present study characterized the translocation t(4;12)(q27~28;q14~15) in four lipomas and showed that it disrupts the HMGA2 locus separating exons 1-3 of the gene from the 3'-untranslated region. This finding contributes to the understanding of HMGA2 genetics in lipomas.
